While balancing vitamin and mineral levels with supplementation may help with some weight loss, it is rarely the only cause of excess weight gain
However, emerging evidence suggests a potential link between GLP-1 therapy and altered pain perception, possibly through several mechanisms: 1- Neuroinflammation and Microglial Activation: GLP-1 receptors are expressed in the brainstem, spinal cord, and dorsal root ganglia, regions involved in pain modulation
Both these hormones are secreted by the intestine after you take in food
"ATTAINMAINTAIN showed that orforglipron, a once-daily oral GLP-1, helped people maintain the weight they worked hard to lose." This data provides the first robust, Phase 3 evidence that an oral "step-down" or "switch" strategy is not just feasible but effective, offering a new pathway for the long-term management of obesity
Why Mounjaro Became Popular for Weight Loss: Although Mounjaro is FDA-approved only for type 2 diabetes, it became widely used off-label for weight loss because: Exceptional Results: Clinical trials showed 15-22% body weight lossbetter than any other weight loss medication available
The FDA Has Explicitly Rejected Cost as a Justification In its April 2026 proposal, the FDA explicitly rejected affordability and insurance access as constituting clinical need for continued bulk compounding